{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:49:24Z","timestamp":1787500164389,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1038\/s41440-023-01265-3","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T04:06:14Z","timestamp":1680149174000},"page":"1582-1595","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A novel vaccine targeting \u03b21-adrenergic receptor"],"prefix":"10.1038","volume":"46","author":[{"given":"Fan","family":"Ke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiajun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingyang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,30]]},"reference":[{"key":"1265_CR1","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/CIRCRESAHA.116.303604","volume":"116","author":"G Grassi","year":"2015","unstructured":"Grassi G, Mark A, Esler M. The sympathetic nervous system alterations in human hypertension. Circ Res. 2015;116:976\u201390.","journal-title":"Circ Res"},{"key":"1265_CR2","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1161\/01.CIR.101.25.2981","volume":"101","author":"MG Sutton","year":"2000","unstructured":"Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation. 2000;101:2981\u201388.","journal-title":"Circulation."},{"key":"1265_CR3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/CIRCRESAHA.113.300308","volume":"113","author":"A Lymperopoulos","year":"2013","unstructured":"Lymperopoulos A, Rengo G, Koch WJ. Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ Res. 2013;113:739\u201353.","journal-title":"Circ Res"},{"key":"1265_CR4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fphys.2020.00076","volume":"11","author":"L Shang","year":"2020","unstructured":"Shang L, Zhang L, Shao M, Feng M, Shi J, Dong Z, et al. Elevated beta1-adrenergic receptor autoantibody levels increase atrial fibrillation susceptibility by promoting atrial fibrosis. Front Physiol. 2020;11:76.","journal-title":"Front Physiol"},{"key":"1265_CR5","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1161\/CIRCRESAHA.118.313884","volume":"123","author":"SF Steinberg","year":"2018","unstructured":"Steinberg SF. Beta1-adrenergic receptor regulation revisited. Circ Res. 2018;123:1199\u2013201.","journal-title":"Circ Res"},{"key":"1265_CR6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1254\/jphs.CRJ06001X","volume":"100","author":"OE Brodde","year":"2006","unstructured":"Brodde OE, Bruck H, Leineweber K. Cardiac adrenoceptors: physiological and pathophysiological relevance. J Pharmacol Sci. 2006;100:323\u201337.","journal-title":"J Pharmacol Sci"},{"key":"1265_CR7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/aps.2011.201","volume":"33","author":"AY Woo","year":"2012","unstructured":"Woo AY, Xiao RP. beta-Adrenergic receptor subtype signaling in heart: from bench to bedside. Acta Pharmacol Sin. 2012;33:335\u201341.","journal-title":"Acta Pharmacol Sin"},{"key":"1265_CR8","first-page":"25","volume":"6","author":"JR Teerlink","year":"2000","unstructured":"Teerlink JR, Massie BM. The role of beta-blockers in preventing sudden death in heart failure. J Card Fail. 2000;6:25\u201333.","journal-title":"J Card Fail"},{"key":"1265_CR9","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398:957\u201380."},{"key":"1265_CR10","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/S0140-6736(17)32478-9","volume":"390","author":"J Lu","year":"2017","unstructured":"Lu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1\u00b77 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet. 2017;390:2549\u201358.","journal-title":"Lancet."},{"key":"1265_CR11","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. Lancet. 2019;394:639\u201351."},{"key":"1265_CR12","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/jama.287.7.883","volume":"287","author":"JM Foody","year":"2002","unstructured":"Foody JM, Farrell MH, Krumholz HM. beta-Blocker therapy in heart failure: scientific review. JAMA. 2002;287:883\u201389.","journal-title":"JAMA."},{"key":"1265_CR13","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s10741-013-9417-4","volume":"19","author":"J Yang","year":"2014","unstructured":"Yang J, Liu Y, Fan X, Li Z, Cheng Y. A pathway and network review on beta-adrenoceptor signaling and beta blockers in cardiac remodeling. Heart Fail Rev. 2014;19:799\u2013814.","journal-title":"Heart Fail Rev"},{"key":"1265_CR14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.7326\/0003-4819-134-7-200104030-00008","volume":"134","author":"JM Brophy","year":"2001","unstructured":"Brophy JM, Joseph L, Rouleau JL. Beta-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Intern Med. 2001;134:550\u201360.","journal-title":"Ann Intern Med"},{"key":"1265_CR15","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","volume":"366","author":"ZM Chen","year":"2005","unstructured":"Chen ZM, Pan HC, Chen YP, Peto R, Collins R, Jiang LX, et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005;366:1622\u201332.","journal-title":"Lancet."},{"key":"1265_CR16","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.jacc.2014.03.014","volume":"63","author":"G Pizarro","year":"2014","unstructured":"Pizarro G, Fern\u00e1ndez-Friera L, Fuster V, Fern\u00e1ndez-Jim\u00e9nez R, Garc\u00eda-Ruiz JM, Garc\u00eda-\u00c1lvarez A, et al. Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction). J Am Coll Cardiol. 2014;63:2356\u201362.","journal-title":"J Am Coll Cardiol"},{"key":"1265_CR17","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.jacc.2016.02.050","volume":"67","author":"JM Garc\u00eda-Ruiz","year":"2016","unstructured":"Garc\u00eda-Ruiz JM, Fern\u00e1ndez-Jim\u00e9nez R, Garc\u00eda-Alvarez A, Pizarro G, Gal\u00e1n-Arriola C, Fern\u00e1ndez-Friera L, et al. Impact of the timing of metoprolol administration during STEMI on infarct size and ventricular function. J Am Coll Cardiol. 2016;67:2093\u2013104.","journal-title":"J Am Coll Cardiol"},{"key":"1265_CR18","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.1021\/acsbiomaterials.0c01201","volume":"6","author":"J Wang","year":"2020","unstructured":"Wang J, Mamuti M, Wang H. Therapeutic vaccines for cancer immunotherapy. ACS Biomater Sci Eng. 2020;6:6036\u201352.","journal-title":"ACS Biomater Sci Eng"},{"key":"1265_CR19","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1098\/rstb.2011.0103","volume":"366","author":"MF Bachmann","year":"2011","unstructured":"Bachmann MF, Jennings GT. Therapeutic vaccines for chronic diseases: successes and technical challenges. Philos Trans R Soc Lond B Biol Sci. 2011;366:2815\u201322.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"1265_CR20","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/HYPERTENSIONAHA.112.201020","volume":"61","author":"X Chen","year":"2013","unstructured":"Chen X, Qiu Z, Yang S, Ding D, Chen F, Zhou Y, et al. Effectiveness and safety of a therapeutic vaccine against angiotensin II receptor type 1 in hypertensive animals. Hypertension. 2013;61:408\u201316.","journal-title":"Hypertension."},{"key":"1265_CR21","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/HYPERTENSIONAHA.119.13700","volume":"74","author":"C Li","year":"2019","unstructured":"Li C, Yan X, Wu D, Zhang K, Liang X, Pan Y, et al. Vaccine targeted alpha 1D-adrenergic receptor for hypertension. Hypertension. 2019;74:1551\u201362.","journal-title":"Hypertension"},{"key":"1265_CR22","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.jacc.2019.02.067","volume":"73","author":"Y Dai","year":"2019","unstructured":"Dai Y, Chen X, Song X, Chen X, Ma W, Lin J, et al. Immunotherapy of endothelin-1 receptor type A for pulmonary arterial hypertension. J Am Coll Cardiol. 2019;73:2567\u201380.","journal-title":"J Am Coll Cardiol"},{"key":"1265_CR23","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1172\/JCI21748","volume":"113","author":"NJ Freedman","year":"2004","unstructured":"Freedman NJ, Lefkowitz RJ. Anti-beta(1)-adrenergic receptor antibodies and heart failure: causation, not just correlation. J Clin Investig. 2004;113:1379\u201382.","journal-title":"J Clin Investig"},{"key":"1265_CR24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cardiores.2007.07.011","volume":"76","author":"TE H\u00e9bert","year":"2007","unstructured":"H\u00e9bert TE. Anti-beta1AR antibodies in dilated cardiomyopathy: are these a new class of receptor agonists? Cardiovasc Res. 2007;76:5\u20137.","journal-title":"Cardiovasc Res"},{"key":"1265_CR25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.tcm.2005.11.002","volume":"16","author":"R Jahns","year":"2006","unstructured":"Jahns R, Boivin V, Lohse MJ. beta(1)-Adrenergic receptor function, autoimmunity, and pathogenesis of dilated cardiomyopathy. Trends Cardiovasc Med. 2006;16:20\u201324.","journal-title":"Trends Cardiovasc Med"},{"key":"1265_CR26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jacc.2007.03.051","volume":"50","author":"VO Nikolaev","year":"2007","unstructured":"Nikolaev VO, Boivin V, St\u00f6rk S, Angermann CE, Ertl G, Lohse MJ, et al. A novel fluorescence method for the rapid detection of functional beta1-adrenergic receptor autoantibodies in heart failure. J Am Coll Cardiol. 2007;50:423\u201331.","journal-title":"J Am Coll Cardiol"},{"key":"1265_CR27","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2265.2010.03831.x","volume":"73","author":"M Evans","year":"2010","unstructured":"Evans M, Sanders J, Tagami T, Sanders P, Young S, Roberts E, et al. Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample. Clin Endocrinol. 2010;73:404\u201312.","journal-title":"Clin Endocrinol"},{"key":"1265_CR28","first-page":"81","volume":"46","author":"P Sanders","year":"2011","unstructured":"Sanders P, Young S, Sanders J, Kabelis K, Baker S, Sullivan A, et al. Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody. J Mol Endocrinol. 2011;46:81\u201399.","journal-title":"J Mol Endocrinol"},{"key":"1265_CR29","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1055\/s-0035-1559648","volume":"47","author":"J Furmaniak","year":"2015","unstructured":"Furmaniak J, Sanders J, N\u00fa\u00f1ez Miguel R, Rees Smith B. Mechanisms of Action of TSHR Autoantibodies. Horm Metab Res. 2015;47:735\u201352.","journal-title":"Horm Metab Res"},{"key":"1265_CR30","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/eurheartj\/12.suppl_D.178","volume":"12","author":"G Wallukat","year":"1991","unstructured":"Wallukat G, Morwinski M, Kowal K, F\u00f6rster A, Boewer V, Wollenberger A. Autoantibodies against the beta-adrenergic receptor in human myocarditis and dilated cardiomyopathy: beta-adrenergic agonism without desensitization. Eur Heart J. 1991;12:178\u201381.","journal-title":"Eur Heart J"},{"key":"1265_CR31","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1161\/01.CIR.89.6.2760","volume":"89","author":"Y Magnusson","year":"1994","unstructured":"Magnusson Y, Wallukat G, Waagstein F, Hjalmarson A, Hoebeke J. Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. Circulation. 1994;89:2760\u201367.","journal-title":"Circulation"},{"key":"1265_CR32","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1161\/01.CIR.99.5.649","volume":"99","author":"R Jahns","year":"1999","unstructured":"Jahns R, Boivin V, Siegmund C, Inselmann G, Lohse MJ, Boege F. Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation. 1999;99:649\u201354.","journal-title":"Circulation."},{"key":"1265_CR33","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI200420149","volume":"113","author":"R Jahns","year":"2004","unstructured":"Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, et al. Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Investig. 2004;113:1419\u201329.","journal-title":"J Clin Investig"},{"key":"1265_CR34","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0735-1097(00)01109-8","volume":"37","author":"M Iwata","year":"2001","unstructured":"Iwata M, Yoshikawa T, Baba A, Anzai T, Mitamura H, Ogawa S. Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2001;37:418\u201324.","journal-title":"J Am Coll Cardiol"},{"key":"1265_CR35","first-page":"679","volume":"57","author":"E Borda","year":"1984","unstructured":"Borda E, Pascual J, Cossio P, De La Vega M, Arana R, Sterin-Borda L. A circulating IgG in Chagas\u2019 disease which binds to beta-adrenoceptors of myocardium and modulates their activity. Clin Exp Immunol. 1984;57:679\u201386.","journal-title":"Clin Exp Immunol"},{"key":"1265_CR36","doi-asserted-by":"crossref","first-page":"e0201160","DOI":"10.1371\/journal.pone.0201160","volume":"13","author":"V Boivin-Jahns","year":"2018","unstructured":"Boivin-Jahns V, Uhland K, Holthoff HP, Beyersdorf N, Kocoski V, Kerkau T, et al. Cyclopeptide COR-1 to treat beta1-adrenergic receptor antibody-induced heart failure. PLoS One. 2018;13:e0201160.","journal-title":"PLoS One"},{"key":"1265_CR37","doi-asserted-by":"crossref","first-page":"eabj9867","DOI":"10.1126\/sciadv.abj9867","volume":"8","author":"H Jin","year":"2022","unstructured":"Jin H, Kishida K, Arase N, Matsuoka S, Nakai W, Kohyama M, et al. Abrogation of self-tolerance by misfolded self-antigens complexed with MHC class II molecules. Sci Adv. 2022;8:eabj9867.","journal-title":"Sci Adv"},{"key":"1265_CR38","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1471-4906(01)01976-7","volume":"22","author":"HA Doyle","year":"2001","unstructured":"Doyle HA, Mamula MJ. Post-translational protein modifications in antigen recognition and autoimmunity. Trends Immunol. 2001;22:443\u201349.","journal-title":"Trends Immunol"},{"key":"1265_CR39","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.autrev.2015.01.013","volume":"14","author":"G Valesini","year":"2015","unstructured":"Valesini G, Gerardi MC, Iannuccelli C, Pacucci VA, Pendolino M, Shoenfeld Y. Citrullination and autoimmunity. Autoimmun Rev. 2015;14:490\u201397.","journal-title":"Autoimmun Rev"},{"key":"1265_CR40","doi-asserted-by":"crossref","unstructured":"Liu C, Luo R, Elliott SE, Wang W, Parchim NF, Iriyama T, et al. Elevated transglutaminase activity triggers angiotensin receptor activating autoantibody production and pathophysiology of preeclampsia. J Am Heart Assoc. 2015;4:e002323.","DOI":"10.1161\/JAHA.115.002323"},{"key":"1265_CR41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/HYPERTENSIONAHA.111.171348","volume":"58","author":"K Wenzel","year":"2011","unstructured":"Wenzel K, Rajakumar A, Haase H, Geusens N, Hubner N, Schulz H, et al. Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats. Hypertension. 2011;58:77\u201384.","journal-title":"Hypertension."},{"key":"1265_CR42","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","volume":"318","author":"N Freemantle","year":"1999","unstructured":"Freemantle N, Cleland J, Young P, Mason J, Harrison J. beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ. 1999;318:1730\u201337.","journal-title":"BMJ."},{"key":"1265_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2021.01.054","volume":"544","author":"Y Wang","year":"2021","unstructured":"Wang Y, Fan Z, Xu C, Yan X, Zhou Y, Qiu Z, et al. Anti-ATR001 monoclonal antibody ameliorates atherosclerosis through beta-arrestin2 pathway. Biochem Biophys Res Commun. 2021;544:1\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"1265_CR44","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/AC.65.5.2056244","volume":"65","author":"F Gorre","year":"2010","unstructured":"Gorre F, Vandekerckhove H. Beta-blockers: focus on mechanism of action. Which beta-blocker, when and why? Acta Cardiol. 2010;65:565\u201370.","journal-title":"Acta Cardiol"},{"key":"1265_CR45","volume":"7","author":"Y Pan","year":"2017","unstructured":"Pan Y, Zhou Y, Wu H, Chen X, Hu X, Zhang H, et al. A therapeutic peptide vaccine against PCSK9. Sci Rep. 2017;7:12534.","journal-title":"Sci Rep"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01265-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01265-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01265-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T19:07:03Z","timestamp":1685905623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01265-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,30]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1265"],"URL":"https:\/\/doi.org\/10.1038\/s41440-023-01265-3","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,30]]},"assertion":[{"value":"6 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was strictly performed according to the recommendations in the Guide for the Care and Use of Laboratory Animals (Science & Technology Department of Hubei Province, China, 2005). The protocol was approved by Animal Care and Use Committee of Hubei Province (Nos. 110324211101061211, 42010200003531, 110011211112453856 and 42010200007174). The animals were fed in a specific pathogen-free animal housing facility with 22\u2009\u2009\u00b0C\u2009\u2009\u00b1\u2009\u20092\u2009\u2009\u00b0C temperature, 60% \u00b15% relative humidity and a 12:12 light: dark cycle. Sterile water and rodent chow were available ad libitum. Every effort was made to minimize animal pain, suffering and distress and to reduce the numbers of animals used. All surgeries were performed under sodium pentobarbital anesthesia.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}